同时耐火性亚托皮肤炎和泛性 Vitiligo 成功用阿布罗西提尼布治疗:一个病例报告
Xinyi Shao1, Xingyu Pan1, Yangmei Chen1
1Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
Journal of asthma and allergy
|December 9, 2024
概括
口服abrocitinib有效地治疗了一名患有严重的亚托皮炎 (AD) 和白病的患者. 这种治疗改善了AD症状,并促进了白病变的再颜色化.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 亚托邦性皮肤炎 (AD) 和白风可以并存,从而带来复杂的治疗挑战.
- 现有的阿尔茨海默病疗法往往具有缓慢发作和不良影响,影响患者的坚持.
- 抗炎症和白风的耐药病例需要新的治疗方法.
研究的目的:
- 报告一个同时患有耐火性亚托皮性皮肤炎和泛性白风的病例.
- 评估口服阿布罗西提尼布在治疗这些并发病的疗效和安全性.
- 探索abrocitinib在治疗白风的耐火性AD的潜在作用.
主要方法:
- 研究了一名65岁的男性患者,患有中度至重度,耐火性AD和泛性白风.
- 最初的治疗包括抗组胺剂和dupilumab注射,其疗效有限.
- 口服abrocitinib用于治疗阿托皮性皮肤炎和白风.
主要成果:
- 患者经历了与AD相关的泛性红疹,斑块和的显著改善.
- 在施用abrocitinib后,观察到白病变的同时复颜.
- 这种治疗在这个患者中表现出了有利的安全性.
结论:
- 口服abrocitinib在治疗耐火性亚托皮性皮肤炎和相关症状方面表现出有效性.
- 阿布罗西替尼在白风病变中促进了再发色,这表明了双重的治疗效益.
- 这一案例提供了证据,证明了abrocitinib在同时患有AD和白症的患者中的潜在安全性和有效性.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
142
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142
Skin Cancer
3.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.4K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
115
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
115


